V
Vericel Corp D
D
VCEL
34.080
USD
1.50
(4.60%)
مغلق
حجم التداول
77,027
الربح لكل سهم
0
العائد الربحي
-
P/E
107
حجم السوق
1,723,562,806
المقالات
العنوان: Vericel Corp
القطاع: Healthcare
الصناعة: Biotechnology
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.


